Search Results
Jun 03, 2026, 10:21 ET KOMISJA EUROPEJSA ZATWIERDZA PREPARAT IMDYLLTRA® FIRMY AMGEN DO LECZENIA DROBNOKOMÓRKOWEGO RAKA PŁUCA W POSTACI ROZSIANEJ
(Tarlatamab u pacjentów z wcześniej leczonym drobnokomórkowym rakiem płuca). N Engl J Med. 2023;389(22):2063-2075.Rojo F, Corassa M, Mavroudis D, et al. International real-world study of DLL3 expression in patients with small cell lung cancer (Międzynarodowe
More news about: Amgen
Jun 03, 2026, 10:16 ET KCC Companies Accelerates Direct-to-Market Growth, Opens Channel Partner Conversations Across North America
920–compliant dedicated outdoor air systems (DOAS) delivering up to 100 percent conditioned outdoor air with the ability to maintain supply dewpoints down to 43°F, at all ambient conditions. Part-load performance is where the specification is won: the integrated seasonal moisture removal efficiency (ISMRE2) ratings
More news about: KCC Manufacturing
Jun 03, 2026, 10:11 ET DXC, 금융기관 핀테크 생태계 연결과 확장을 도와주는 DXC CoreIgnite 출시
multimedia:https://www.prnewswire.com/kr/news-releases/u0064u0078u0063u002Cu002DuAE08uC735uAE30uAD00u002DuD540uD14CuD06Cu002DuC0DDuD0DCuACC4u002DuC5F0uACB0uACFCu002DuD655uC7A5uC744u002DuB3C4uC640-302790325.htmlSOURCE
More news about: DXC Technology Company
Jun 03, 2026, 10:06 ET From the Flight Line to the Index: Starfighters Space (FJET) Joins the Russell 3000®
Operating from NASA's Kennedy Space Center in Florida, Starfighters Space maintains what it describes as the world's only commercial fleet of flight-ready F-104 supersonic aircraft capable of sustained MACH 2+ operations. That fleet is the foundation of a deliberately different approach to reaching the edge
More news about: USA News Group
Jun 03, 2026, 09:43 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN IMDYLLTRA® ДЛЯ ЛЕЧЕНИЯ МЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКОГО НА ЗАПУЩЕННОЙ СТАДИИ
MJ, Cho BC, Felip E, et al. Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med. 2023;389(22):2063-2075.Rojo F, Corassa M, Mavroudis D, et al. International real-world study of DLL3 expression in patients with small cell lung cancer. Lung Cancer. 2020;147:237-243.International
More news about: Amgen
Jun 03, 2026, 09:30 ET TAT Technologies Secures $45 Million in Long-Term MRO Contract Awards
and other risks detailed from time to time in the Company's filings with the Securities Exchange Commission, including, its annual report on form 20-F and its periodic reports on form 6-K. These documents contain and identify other important factors that could cause actual results to differ materially
More news about: TAT Technologies Ltd
Jun 03, 2026, 09:28 ET MetaOptics Ltd 關於擬議於納斯達克證券交易所進行雙重上市之最新進展
9MT)（「MetaOptics」或「本公司」，連同其子公司統稱「本集團」）謹此向本公司股東（「股東」）匯報，本公司就擬議於納斯達克證券交易所作雙重上市的計畫目前仍按原定時間表推進，並將就任何重大進展情況持續向股東作出更新。 如本公司於2026年5月19日之公告所述，本公司已於2026年5月18日根據美國《證券法》向美國證券交易委員會（SEC）提交經修訂之Form F‑1 註冊聲明（「註冊聲明」），以反映包括擬發行之美國預託股份（ADSs）的數量，以及每一發售ADS所代表之標的股份數目及其換算比例等事項。本公司已於2026年5月28日接獲新加坡證券交易所有限公司（「新交所」）就本公司擬發行新普通股（「新股」）並在本公司股本中上市及掛牌買賣所發出的上市及報價資格預審通知書（listing
More news about: METAOPTICS LTD
Jun 03, 2026, 09:27 ET LA CE APRUEBA IMDYLLTRA® DE AMGEN PARA EL CÁNCER DE PULMÓN DE CÉLULAS PEQUEÑAS EN ESTADIO AVANZADO
Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med. 2023;389(22):2063-2075.Rojo F, Corassa M, Mavroudis D, et al. International real-world study of DLL3 expression in patients with small cell lung cancer. Lung
More news about: Amgen
Jun 03, 2026, 09:26 ET MAHA PAC Celebrates Historic Victory as Zach Lahn Wins Iowa Republican Primary for Governor
victory reflects mounting grassroots momentum behind the Make America Healthy Again movement led nationally by Health and Human Services Secretary Robert F. Kennedy Jr. and focused on rebuilding public trust in health institutions, eliminating chronic disease, protecting children from environmental toxins,
More news about: MAHA PAC
Jun 03, 2026, 09:15 ET Xiao-I Corporation Regains Full Compliance with Nasdaq Continued Listing Standards
Additional factors are discussed in the Company's filings with the SEC, including under the section entitled "Risk Factors" in its annual report on Form 20-F/A filed with the SEC on May 22, 2026, as well as its current reports on Form 6-K and other filings, all of which are available for review at
More news about: Xiao-I Corporation
Jun 03, 2026, 09:00 ET Cambium Launches ApexShield 3000: A Dual-Use Protective Coating Engineered for High-Temperature Performance
is a sprayable, solvent-based 1-part liquid that cures at temperatures as low as 215°C (419°F) and delivers sustained operational performance up to 315°C (600°F), with short-duration capability up to 427°C (800°F). The system requires no refrigerated storage and is available in quarts, gallons, and drums,
More news about: Cambium Biomaterials, Inc
Jun 03, 2026, 09:00 ET Cambium Launches ApexShield 3000: A Dual-Use Protective Coating Engineered for High-Temperature Performance
is a sprayable, solvent-based 1-part liquid that cures at temperatures as low as 215°C (419°F) and delivers sustained operational performance up to 315°C (600°F), with short-duration capability up to 427°C (800°F). The system requires no refrigerated storage and is available in quarts, gallons, and drums,
More news about: Cambium Biomaterials, Inc
Jun 03, 2026, 09:00 ET Getac's new 8-inch ZX80W tablet blends Windows 11 functionality with energy-efficient fanless design for all-day productivity in the field
IP67 certified, vibration, and 6ft (1.8m) drop resistant. It also features a sunlight-readable display and a wide operating temperature range of -20°F to 145°F (-29°C to 63°C). Despite all this, the ZX80W weighs just 1.3lbs (590g), making it incredibly lightweight for extended use in the field."Effective
More news about: Getac Technology Corporation
Jun 03, 2026, 09:00 ET POET DEADLINE: Levi & Korsinsky Reminds POET Technologies Inc. Investors of Upcoming Securities Class Action Deadline
breaches. The lead plaintiff deadline is June 29, 2026.What the Company Disclosed in SEC FilingsPOET's 2025 Annual Report on Form 20-F, filed March 31, 2026, included risk factor language stating the Company "may be treated as a PFIC for the preceding taxable year." The filing acknowledged
More news about: Levi & Korsinsky, LLP
Jun 03, 2026, 08:54 ET Lennox Cold Climate Heat Pump Earns GOOD DESIGN® Recognition for Reliable Performance in Extreme Conditions
Award highlights innovative design, dependable operation to -20°F, and lasting homeowner confidenceDALLAS, June 3, 2026 /PRNewswire/ --
More news about: Lennox International Inc.
Jun 03, 2026, 08:43 ET Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Miller Kaplan Arase LLP, for Alleged Failure to Provide Required Meal Periods and Rest Periods
overtime wages, (c) failed to provide accurate itemized wage statements, (d) failed to reimburse for required expenses, (e) failed to pay sick wages, and (f) failed to provide wages when due, all in violation of the applicable Labor Code sections listed in California Labor Code Sections 201-203, 226, 226.7,
More news about: Blumenthal Nordrehaug Bhowmik De Blouw LLP
Jun 03, 2026, 08:37 ET Mark Tabakin and 6-Attorney Team Join Scarinci Hollenbeck, Advancing Statewide Vision
Joseph F. Ranieri, Counsel — Redevelopment, tax appeals, public housing
More news about: Scarinci Hollenbeck, LLC
Jun 03, 2026, 08:37 ET Infosys und LTA führen bei den HSBC Championships und darüber hinaus KI-gesteuerte Spiel- und Fanerlebnisse ein
the forward-looking statements are discussed in more detail in our US Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2025. These filings are available at www.sec.gov.
More news about: Infosys
Jun 03, 2026, 08:32 ET Zinzino AB (publ.): 250 International chefs and sommeliers recognize Zinzino's BalanceOil+ with 2026 Superior Taste Award
https://mb.cision.com/Public/10976/4357234/932d20aca5e6f4eb.pdf2606 Press release
More news about: Zinzino
Jun 03, 2026, 08:30 ET Neurocrine Biosciences to Present New Two‑Year CRENESSITY® (crinecerfont) Data on Key Clinical and Patient‑Reported Outcome Measures at ENDO 2026
with Diazoxide Choline Extended-Release in Participants with Prader-Willi Syndrome (Poster Presentation #SUN-688)Authors: Evelien F. Gevers, M.D., Ph.D., et alDate/Time: June 14 from 12:00-1:30 PMTitle: Impact of Long-Term Diazoxide Choline Extended-Release Treatment
More news about: Neurocrine Biosciences, Inc.
Jun 03, 2026, 08:28 ET ATI Announces Proposed Senior Notes Offering
(e) declines in the value of our defined benefit pension plan assets or unfavorable changes in laws or regulations that govern pension plan funding; (f) labor disputes or work stoppages; (g) equipment outages; (h) business and economic disruptions associated with extraordinary events beyond our control,
More news about: ATI
Jun 03, 2026, 08:01 ET ExhaustFlow Technologies Launches Patented Cooling System That Delivers Up to 25% More Cooling Capacity and Cuts Energy Costs in Data Centers
compact mechanical yards create recirculation loops in which hot discharge air re-enters condenser coils, raising inlet temperatures 10 to 30 degrees F above design ambient. The result is silent, measurable degradation: reduced chiller capacity, increased energy consumption, elevated electrical infrastructure
More news about: ExhaustFlow Technologies
Jun 03, 2026, 08:00 ET CAS Connections bringt zuverlässige wissenschaftliche Daten und KI auf führende F&E-Plattformen
sagte Tim Wahlberg, Interim President von CAS. „Durch die Integration mit diesen Plattformen wird der Mehrwert, den CAS innerhalb digitaler F&E-Arbeitsabläufe bietet, rasch erweitert, sodass Forschern fundiertes wissenschaftliches Wissen genau dort zur Verfügung steht, wo sie bereits arbeiten."Die
More news about: CAS
Jun 03, 2026, 08:00 ET SKINCEUTICALS、SCUDERIA FERRARI HPの公式スキンケアパートナーに就任
--世界ナンバーワンのメディカルエステティック・スキンケアブランドであるSkinCeuticalsは、F1レーシングチームの象徴であるScuderia
More news about: SkinCeuticals
Jun 03, 2026, 08:00 ET 스킨수티컬즈, 스쿠데리아 페라리 HP의 공식 스킨케어 파트너로 선정
영역으로 확장하는 중요한 계기가 될 것"이라고 말했다.이번 종합 파트너십은 F1 시즌 전반을 따라가는 글로벌 캠페인을 통해 처음 공개된다. 이를 통해 성과 중심의 스킨케어 소비자와 스쿠데리아 페라리 HP 팬들에게 주요 플랫폼 전반에서 다가갈 예정이다. 스킨수티컬즈는 다년간 이어질 캠페인 기간에 강력한 스토리텔링과 프리미엄 호스피탈리티 프로그램, 세계 주요 그랑프리 대회 현장에서 진행되는 독점 체험 프로그램을 통해 브랜드의 제품 및 임상 전문성을 F1 무대에 선보일 계획이다.로렌초 조르제티(Lorenzo Giorgetti)
More news about: SkinCeuticals